News coverage about VirtualScopics (NASDAQ:VSCP) has been trending somewhat positive on Sunday, AlphaOne Sentiment Analysis reports. The research firm, a division of Accern, identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. VirtualScopics earned a news sentiment score of 0.12 on AlphaOne’s scale. AlphaOne also assigned press coverage about the medical equipment provider an impact score of 83 out of 100, indicating that recent press coverage is very likely to have an impact on the stock’s share price in the next few days.

Shares of VirtualScopics (NASDAQ:VSCP) opened at 4.04 on Friday. The firm’s 50-day moving average price is $4.05 and its 200 day moving average price is $3.54. VirtualScopics has a one year low of $1.73 and a one year high of $6.65.

TRADEMARK VIOLATION NOTICE: This article was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/05/21/somewhat-positive-media-coverage-very-likely-to-affect-virtualscopics-vscp-share-price-updated-updated-updated.html.

About VirtualScopics

VirtualScopics, Inc is a provider of imaging services serving the pharmaceutical and biotechnology industries in early and late-stage clinical trials. The Company offers a range of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images.

12 Month Chart for NASDAQ:VSCP

Receive News & Stock Ratings for VirtualScopics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VirtualScopics Inc and related stocks with our FREE daily email newsletter.